BackgroundThe menopausal transition represents a critical period for musculoskeletal health. Progressive strength training is highly effective in mitigating musculoskeletal declines during this transition, yet fewer than 25% of women in midlife meet strength training guidelines. Scalable interventions are needed.MethodsThe Stronger trial is a 2×2+1 factorial randomized clinical trial evaluating a 12-week, remotely-delivered strength training program for women in perimenopause, followed by a 12-week maintenance phase. Assessments will occur at baseline, 6, 12, and 24 weeks. Participants (n=90) will be randomized to one of four conditions or a waitlist control, testing: (1) exercise schedule: distributed "snacks" (1–2 exercises, 3 times/day, two days/week) versus consolidated "sessions" (5 exercises, 1 time/day, two days/week); and (2) tracking simplicity: simplified versus detailed self-monitoring. All participants will receive progressive overload training with sandbag weights, weekly virtual office hours, perimenopause education, and protein intake guidance (goal: 1.6 g/kg/day). The primary outcome is 12-week adherence, measured as total exercise completed out of total prescribed (5 exercises, 3 high effort sets, 2 days per week). Secondary outcomes include maintenance-phase adherence, intervention engagement, and changes in hamstring and quadriceps strength (via handheld dynamometry), sit-to-stands, and step power. Exploratory outcomes include body composition (DXA), functional performance, and psychosocial measures.ResultsRecruitment began in June 2025, with data collection anticipated to end in summer 2026.ConclusionsStronger will identify whether breaking strength sessions into snacks improves adherence, and evaluate the feasibility and acceptable delivery strategies of a scalable digital strength training intervention for perimenopausal women.